$WOOF

The article says the $44 billion global wearables industry is shifting from fitness tracking toward healthcare integration, citing Apple, Samsung, Google and Fitbit, plus Oura’s 2021 Fitbit purchase by Google. It notes Oura sued competitors over patents and has pending cases, and mentions Apple’s Epic Systems partnership and Oura’s Dexcom investment. It also cites Whoop’s FDA dispute over blood pressure guidance.

Petco Health & Wellness Company, Inc. (WOOF) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K 0001826470 false 0001826470 2026-07-31 2026-07-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31,

Petco Health & Wellness Company, Inc. (WOOF) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K 0001826470 false 0001826470 2026-07-13 2026-07-13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13,

Petco Health and Wellness (NASDAQ:WOOF) shares fell about 1.6% in premarket after its CHRO Holly May sold 200,000 shares on July 9, according to an SEC Form 4. The weighted average sale price was $2.54, totaling about $508,000. May retains 1,327,867 shares, including RSUs tied to the 2021 equity plan.

May Holly (Chief Human Resources Officer) sold 200,000 shares of Petco Health & Wellness Company, Inc. (WOOF) at $2.54 ($0.51M total) on 2026-07-09.

May Holly (Chief Human Resources Officer) sold 250,000 shares of Petco Health & Wellness Company, Inc. (WOOF) at $2.55 ($0.64M total) across 2 trades over 2026-07-07 to 2026-07-08.

Petco Health and Wellness (NASDAQ:WOOF) reported FQ1 2026 results on June 3: net sales of $1.5B, comparable sales growth of 0.7%, gross profit of $574.4M, and operating income improvement despite a $15.1M net loss. The company reduced total debt to $1.482B and ended with $166.8M cash, reaffirming its full-year 2026 outlook.

The article cites Reuters (June 30, 2026) on market tests for sustaining the 2026 rally, including AI spending, earnings expectations, and Fed policy. It then lists penny stocks, focusing on Petco (WOOF) and Lithium Americas (LAC): WOOF reported Q1 2026 net sales $1.5B and guided FY 2026 adj. EBITDA $415–$430M; LAC reported progress toward Thacker Pass mechanical completion in late 2027 and targets 2026 capex $1.3–$1.6B. Analyst price targets were updated for both.

Petco Health & Wellness Company, Inc. (WOOF) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K false 0001826470 0001826470 2026-06-30 2026-06-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30,

Citigroup cut its Petco Health and Wellness (WOOF) price target to $3.25 from $4.00 and kept a “neutral” rating, according to a Thursday research note cited by Benzinga. WOOF traded at $2.82, down 7.6%. The article also notes Petco’s March 11 quarter: EPS -$0.01 vs $0.02 expected, revenue $1.52B vs $1.51B.